Human centred design of an affordable insulin delivery innovation for people with diabetes in developing countries

3B Impact与创新公司合作，为全球挑战提供解决方案。它正与GO-Pen Aps的糖尿病设备专家和英国无国界医生组织的经验丰富的从业人员合作，将一种创新的胰岛素输送系统商业化，该系统专为马来西亚等发展中国家的低收入糖尿病患者设计。胰岛素输送系统专为富裕市场设计。虽然富人买得起胰岛素笔，但1300万患有糖尿病的穷人每天使用注射器注射3-4次胰岛素。这些都不适合的目的。注射器使其更难提供正确的剂量，导致并发症，包括失明，截肢和死亡，并产生大量的危险废物。一次性使用的注射器经常被多次使用，有感染的风险。GO-Pen的解决方案消除了对注射器的需要，更安全，更实惠。好处是：1.更快、更离散的注射;2.精确的剂量;3.减少对医疗保健专业人员的培训;4.更容易使用，导致更好的治疗;5。降低并发症的风险;6.降低成本; 7.减少有害废物。成功取决于确保用户想要使用GO-Pen，并改善胰岛素的使用方式，这是该项目的重点。

3B Impact works with innovative companies to scale solutions to global challenges. It is working with diabeties device experts at GO-Pen Aps and experienced practitioners at Médecins Sans Frontières UK to commercialise an innovative insulin delivery system, designed specifically for diabetics on low incomes in developing countries, such as Malaysia.Insulin delivery systems are designed for affluent markets. While the rich can afford insulin pens, 13 million poor people with diabetes take insulin through 3-4 daily injections using syringes. These are not fit for purpose. Syringes make it harder to deliver correct dosages leading to complications including blindness, amputations and death, and produce significant amounts of hazardous waste. Single use syringes are often used multiple times, risking infection.GO-Pen's solution eliminates the need for syringes, is safer and more affordable. The benefits are:1. a quicker, more discrete injection;2. precise dosing;3. less training needed from healthcare professionals;4. easier to use leading to better treatment;5. lower risk of complications;6. reduced cost; and7. reduced hazardous waste.Success depends on ensuring users want to use the GO-Pen and that it improves how insulin is used, the focus of this project.